Home › Research › Disease mechanisms
The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke
Nada Hamad Aljarba, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Mustafa M Shokr, Marios Papadakis, Athanasios T. Alexiou, Mubarak Alruwaili, Mohammed Alrouji et al.. Brain Research Bulletin, 2025-01-30
Topic: Brain proteins, microglia and lab models
Plain-language summary
The advanced glycation end-products (AGEs) are toxic molecules result from non-enzymatic interactions of sugar with lipids or proteins. AGEs promote the generation of reactive oxygen species that induce the release of pro-inflammatory cytokines, and alter the intracellular signaling leading to progressive biochemical and metabolic derangements. AGEs-induced cellular aging is implicated in the development and progression of different neurological disorders such as dementia, neuropsychiatric disorders, and cerebrovascular diseases. Particularly, AGEs-induced microangiopathy and macroangiopathy trigger the induction of prothrombotic/thrombotic cascades with subsequent increase risk of acute ischemic stroke (AIS). Many studies highlighted that AGEs serum levels are correlated with the incidence, pathogenicity, and severity of AIS. However, the relationship between AGEs and AIS is not elucidated completely. Therefore, this review aims to discuss how AGEs promote the development and progression of AIS, and how AGEs inhibitors could be effective in the management of AIS.
What this study adds
Evidence grade: Low
This review discusses how advanced glycation end-products may contribute to ischemic stroke and whether inhibitors of them could help manage stroke. It concerns stroke, not treating, curing or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Aljarba, N. H., Al-Kuraishy, H. M., Al-Gareeb, A. I., Shokr, M. M., Papadakis, M., Alexiou, A. T., et al. (2025). The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke. Brain Research Bulletin. https://doi.org/10.1016/j.brainresbull.2025.111236
Vancouver
Aljarba NH, Al-Kuraishy HM, Al-Gareeb AI, Shokr MM, Papadakis M, Alexiou AT, et al. The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke. Brain Research Bulletin. 2025. doi:10.1016/j.brainresbull.2025.111236. PMID: 39892578.
BibTeX
@article{aljarba2025-39892578,
author = {Aljarba, Nada Hamad and Al-Kuraishy, Hayder Mutter and Al-Gareeb, Ali Ismail and Shokr, Mustafa M and Papadakis, Marios and Alexiou, Athanasios T. and Alruwaili, Mubarak and Alrouji, Mohammed and others},
title = {{The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke}},
journal = {Brain Research Bulletin},
year = {2025},
doi = {10.1016/j.brainresbull.2025.111236},
pmid = {39892578},
url = {https://doi.org/10.1016/j.brainresbull.2025.111236}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The advanced glycation end-products (AGEs) are toxic molecules result from non-enzymatic interactions of sugar with lipids or proteins.
Why it matters
This review discusses how advanced glycation end-products may contribute to ischemic stroke and whether inhibitors of them could help manage stroke. It concerns stroke, not treating, curing or preventing Alzheimer's disease.
Study details
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Brain Research Bulletin) |
| Journal's citation record | 2 / 4 | Brain Research Bulletin: journal h-index 203 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 9 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 4.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 9 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Gaber El‐Saber Batiha: h-index 72 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Witten/Herdecke University: institution h-index 335 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 9 institution(s) in 5 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39892578) |
| Free to read | 2 / 2 | Free to read |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.brainresbull.2025.111236
- PubMed: 39892578
- Original source →
- Free full text: Brain Research Bulletin →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Disease mechanisms from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.